The misconception
It prompts a natural hormone, so there cannot be a serious downside.
What the facts say
Natural-sounding claims do not settle safety. The FDA record checked as of September 28, 2026 includes serious reactions linked to CJC-1295.
See the source notesKnow what the FDA has flagged
The FDA, the Food and Drug Administration, reports serious reactions linked to CJC-1295 use: a faster heart rate and widening of blood vessels, the tubes that carry blood.
Those reactions can include skin turning red, a feeling of warmth and low blood pressure.
The FDA review says long-term safety in people remains unknown.
These are concerns in the records checked September 28, 2026, not a prediction of what will happen to any one person.
Look past the badge
An offer may say “FDA registered” or show a drug on an FDA list stored on a computer. As of September 26, 2026, neither claim means FDA approval.
An offer may also include a National Drug Code (NDC) number. It identifies a listing in a government drug record; it does not mean CJC-1295 is approved.
Ask for the exact evidence behind any approval claim.
Check the person and the source
A doctor or other health professional with permission to prescribe gives a medicine order called a prescription.
FDA’s online-pharmacy checklist calls for that order, a licensed pharmacist who can answer questions, and a state pharmacy licence.
Ask which pharmacy would make or supply any agreed medicine, then check the state record.
A pharmacy licence shows permission to run a pharmacy. It does not give permission to make medicine with CJC-1295.
“Research use only” does not mean approved for people
FDA letters checked September 26, 2026 describe products labelled “research use only” but promoted as treatments for people. The FDA said these were unapproved drugs being sold across state lines against the law.
These letters say what the FDA believes the named sellers did wrong. They are not court decisions about those sellers.
When reading an offer, look at what it promises to do for your health, as well as the label. A research label gives no proof of approval or lawful medical sale.
When the question is urgent
The health guide MedlinePlus comes from the US National Library of Medicine and calls a severe allergic reaction an emergency.
MedlinePlus advises going to the closest emergency room when symptoms are severe; examples include a swollen tongue or trouble breathing.
This is general emergency guidance checked September 17, 2026; it does not identify the cause of a reaction.
For questions about an offer, keep the claim and the product name handy for a doctor or other health professional to review.
Open the evidence
The compound concerns were checked September 28, 2026.
The FDA reports reactions linked to CJC-1295 use; a link alone does not prove the cause of each reaction. Long-term safety remains unknown. The emergency advice does not tell you what caused a reaction.
- FDA’s concerns beside the entry
Describes serious reactions reported with use and the shortage of information from studies in people.
- FDA’s state-pharmacy lookup page
Go to the relevant state record to check a pharmacy.
- What FDA approval does and does not mean
Explains why an official-looking registration claim is not enough.
- FDA’s online-pharmacy checklist
Gives the signs to check when weighing an online pharmacy.
- FDA’s reasoning about research labels
Read what the FDA said a seller did wrong. This is a warning letter, not a court decision.
- MedlinePlus on severe allergic reactions
Supports the general emergency guidance above.
Keep a question for later
Notes stay in this browser.
Nothing saved yet.